METHYSERGIDE AND METERGOLINE REDUCE MORPHINE ANALGESIA WITH NO EFFECT ON THE DEVELOPMENT OF TOLERANCE IN RATS

被引：0
作者：
ROMANDINI, S [1 ]
SAMANIN, R [1 ]
机构：
[1] MARIO NEGRI INST PHARMACOL RES,VIA ERITREA 62,I-20157 MILAN,ITALY
来源：
PSYCHOPHARMACOLOGY | 1984年 / 82卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：140 / 142
页数：3
相关论文
共 23 条
[1]   EFFECTS OF 5,6-DIHYDROXYTRYPTAMINE ON MONOAMINERGIC NEURONS IN CENTRAL NERVOUS-SYSTEM OF RAT [J].
BAUMGARTEN, HG ;
IVERSEN, LL ;
WILSON, G ;
VOGT, M ;
HOLMAN, RB ;
EVETTS, KD .
JOURNAL OF NEUROCHEMISTRY, 1972, 19 (06) :1587-+
[2]   EVIDENCE OF A PREFERENTIAL ROLE OF BRAIN-SEROTONIN IN THE MECHANISMS LEADING TO NALOXONE-PRECIPITATED COMPULSIVE JUMPING IN MORPHINE-DEPENDENT RATS [J].
CERVO, L ;
ROCHAT, C ;
ROMANDINI, S ;
SAMANIN, R .
PSYCHOPHARMACOLOGY, 1981, 74 (03) :271-274
[3]  
CHENEY DL, 1971, J PHARMACOL EXP THER, V177, P309
[4]   DECREASE OF TOLERANCE DEVELOPMENT TO MORPHINE BY 5-HYDROXYTRYPTOPHAN AND SOME RELATED DRUGS [J].
CONTRERAS, E ;
TAMAYO, L ;
QUIJADA, L ;
SILVA, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1973, 22 (03) :339-343
[5]   INVOLVEMENT OF PERIAQUEDUCTAL GREY MATTER AND SPINAL 5-HYDROXYTRYPTAMINERGIC PATHWAYS IN MORPHINE ANALGESIA - EFFECTS OF LESIONS AND 5-HYDROXYTRYPTAMINE DEPLETION [J].
DEAKIN, JFW ;
DOSTROVSKY, JO .
BRITISH JOURNAL OF PHARMACOLOGY, 1978, 63 (01) :159-165
[6]   EFFECTS OF METHERGOLINE ON CENTRAL MONOAMINE NEURONS - EVIDENCE FOR A SELECTIVE BLOCKADE OF CENTRAL 5-HT RECEPTORS [J].
FUXE, K ;
AGNATI, L ;
EVERITT, B .
NEUROSCIENCE LETTERS, 1975, 1 (05) :283-290
[7]   A BEHAVIORAL AND BIOCHEMICAL-STUDY IN RATS OF 5-HYDROXYTRYPTAMINE RECEPTOR AGONISTS AND ANTAGONISTS, WITH OBSERVATIONS ON STRUCTURE-ACTIVITY REQUIREMENTS FOR THE AGONISTS [J].
GREEN, AR ;
HALL, JE ;
REES, AR .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 73 (03) :703-719
[8]  
HO IK, 1972, J PHARMACOL EXP THER, V182, P155
[9]   INFLUENCE OF 5,6-DIHYDROXYTRYPTAMINE ON MORPHINE-TOLERANCE AND PHYSICAL DEPENDENCE [J].
HO, IK ;
LOH, H ;
LEONGWAY, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1973, 21 (03) :331-336
[10]  
JANSSEN PAJ, 1963, ARZNEIMITTEL-FORSCH, V13, P502
123